
Pioneering anti-fungal and anesthetic APIs, trusted by pharmaceutical leaders worldwide.

CONTRIBUTION TO GUFIC GROUP TURNOVER
REVENUE FROM
EXPORTS
MARKET SHARE IN INDIA'S PRILOCAINE EXPORTS
DOMESTIC MARKET
SUPPLY
INTERNATIONAL MARKET
SUPPLY
Gufic's API business plays a vital role in enabling cost-effective formulations through backward integration. APIs manufactured in-house directly feed into Gufic's own formulation lines, driving down costs and ultimately making medicines more affordable for a wider population.
With anti-fungal and anesthetic APIs leading sales, Gufic supplies to markets across the Middle East, LATAM, Eastern Europe, SEA, Germany, Australia, Russia, Japan, China, Brazil, and Korea. In a notable distinction, Gufic exports Prilocaine API to China — the world's largest API manufacturer.

An amide-type local anesthetic widely used in dentistry and surface anesthesia to induce temporary numbness. Available as Prilocaine Base and Prilocaine Hydrochloride.
A non-beta-lactam beta-lactamase inhibitor used in combination with ceftazidime to treat multidrug-resistant Gram-negative bacterial infections.
An amide-type local anesthetic and antiarrhythmic agent used widely for pain control through nerve blockade.
A broad-spectrum imidazole antifungal agent that treats skin and vaginal yeast infections by inhibiting fungal cell membrane synthesis.
A broad-spectrum antifungal active against dermatophytes, yeasts, and molds, used in dermatological and vaginal formulations.
A broad-spectrum antifungal API of the imidazole class, used primarily in dermatological preparations.
| API | Monthly Capacity |
|---|---|
| Lidocaine HCL | 10 MT |
| Lidocaine Base | 5 MT |
| Miconazole Nitrate | 5 MT |
| Isoconazole Nitrate | 3 MT |
| Miconazole | 3 MT |
| Prilocaine | 2.5 MT |
| Econazole | 2 MT |